Vlasie A, Trifu S, Lupuleac C, Kohn B, Cristea M
Exp Ther Med. 2022; 23(2):185.
PMID: 35069866
PMC: 8764906.
DOI: 10.3892/etm.2021.11108.
Manconi M, Garcia-Borreguero D, Schormair B, Videnovic A, Berger K, Ferri R
Nat Rev Dis Primers. 2021; 7(1):80.
PMID: 34732752
DOI: 10.1038/s41572-021-00311-z.
Ghorayeb I
Adv Exp Med Biol. 2021; 1297:173-181.
PMID: 33537945
DOI: 10.1007/978-3-030-61663-2_13.
Lv Q, Wang X, Asakawa T, Wang X
Curr Neuropharmacol. 2020; 19(3):372-382.
PMID: 33380302
PMC: 8033969.
DOI: 10.2174/1570159X19666201230150127.
Salminen A, Winkelmann J
Curr Treat Options Neurol. 2018; 20(12):55.
PMID: 30411165
DOI: 10.1007/s11940-018-0540-3.
Differential Dopamine D1 and D3 Receptor Modulation and Expression in the Spinal Cord of Two Mouse Models of Restless Legs Syndrome.
Meneely S, Dinkins M, Kassai M, Lyu S, Liu Y, Lin C
Front Behav Neurosci. 2018; 12:199.
PMID: 30233336
PMC: 6131574.
DOI: 10.3389/fnbeh.2018.00199.
Circadian Change in Blink Reflex Recovery in Restless Legs Syndrome.
Uzun N, Gunduz A, Karadeniz D, Kiziltan M
Noro Psikiyatr Ars. 2017; 53(3):263-266.
PMID: 28373805
PMC: 5378201.
DOI: 10.5152/npa.2015.10241.
Interventions for chronic kidney disease-associated restless legs syndrome.
Gopaluni S, Sherif M, Ahmadouk N
Cochrane Database Syst Rev. 2016; 11:CD010690.
PMID: 27819409
PMC: 6464953.
DOI: 10.1002/14651858.CD010690.pub2.
Treatment Options in Intractable Restless Legs Syndrome/Willis-Ekbom Disease (RLS/WED).
Rinaldi F, Galbiati A, Marelli S, Strambi L, Zucconi M
Curr Treat Options Neurol. 2016; 18(2):7.
PMID: 26874840
DOI: 10.1007/s11940-015-0390-1.
Treatment of restless legs syndrome.
Comella C
Neurotherapeutics. 2013; 11(1):177-87.
PMID: 24363103
PMC: 3899490.
DOI: 10.1007/s13311-013-0247-9.
The effect of ropinirole on the quality of life in patients with restless legs syndrome in Korea: an 8-week, multicenter, prospective study.
Cho Y, Bong Hong S, Kim D, Lee H, Joo E, Kim J
J Clin Neurol. 2013; 9(1):51-6.
PMID: 23346161
PMC: 3543910.
DOI: 10.3988/jcn.2013.9.1.51.
Strategies for the treatment of restless legs syndrome.
Buchfuhrer M
Neurotherapeutics. 2012; 9(4):776-90.
PMID: 22923001
PMC: 3480566.
DOI: 10.1007/s13311-012-0139-4.
Pramipexole in restless legs syndrome: an evidence-based review of its effectiveness on clinical outcomes.
Winlow W
Core Evid. 2012; 1(1):35-42.
PMID: 22496675
PMC: 3321653.
Sleep-related movement disorders.
Merlino G, Gigli G
Neurol Sci. 2011; 33(3):491-513.
PMID: 22203333
DOI: 10.1007/s10072-011-0905-9.
Levodopa for restless legs syndrome.
Scholz H, Trenkwalder C, Kohnen R, Riemann D, Kriston L, Hornyak M
Cochrane Database Syst Rev. 2011; (2):CD005504.
PMID: 21328278
PMC: 8889887.
DOI: 10.1002/14651858.CD005504.pub2.
Dopamine D3 receptor specifically modulates motor and sensory symptoms in iron-deficient mice.
Dowling P, Klinker F, Stadelmann C, Hasan K, Paulus W, Liebetanz D
J Neurosci. 2011; 31(1):70-7.
PMID: 21209191
PMC: 6622742.
DOI: 10.1523/JNEUROSCI.0959-10.2011.
Progressive development of augmentation during long-term treatment with levodopa in restless legs syndrome: results of a prospective multi-center study.
Hogl B, Garcia-Borreguero D, Kohnen R, Ferini-Strambi L, Hadjigeorgiou G, Hornyak M
J Neurol. 2009; 257(2):230-7.
PMID: 19756826
PMC: 3085743.
DOI: 10.1007/s00415-009-5299-8.
Pramipexole: new use for an old drug - the potential use of pramipexole in the treatment of restless legs syndrome.
Benbir G, Guilleminault C
Neuropsychiatr Dis Treat. 2009; 2(4):393-405.
PMID: 19412489
PMC: 2671938.
DOI: 10.2147/nedt.2006.2.4.393.
Sleep disturbances in patients with schizophrenia : impact and effect of antipsychotics.
Cohrs S
CNS Drugs. 2008; 22(11):939-62.
PMID: 18840034
DOI: 10.2165/00023210-200822110-00004.
Restless legs syndrome.
Bernick C, Stern L
West J Med. 1986; 145(2):263-5.
PMID: 18750059
PMC: 1306908.
